Actinium Pharmaceuticals, Inc.
ATNM
Revenue
90.00k
▲90.00k∞%
33 Months ChangeAssets
56.15M
▼-6.87M▼-10.90%
3 Months ChangeLiabilities
42.37M
▼-1.64M▼-3.72%
3 Months ChangeFree Cash Flow
-7.39M
▲7.77M▲51.26%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-13
Form 8-K
ID: 0001213900-26-016559
2025-11-26
Form 8-K
ID: 0001213900-25-115586
2025-11-14
Form 10-Q
ID: 0001213900-25-110979
2025-08-08
Form 10-Q
ID: 0001213900-25-073743
2025-05-09
Form 10-Q
ID: 0001213900-25-041614
2025-05-09
Form 8-K
ID: 0001213900-25-041582
2024-11-27
Form 8-K
ID: 0001213900-24-103498
2024-11-14
Form 10-Q
ID: 0001213900-24-098534
2024-11-05
Form 8-K
ID: 0001213900-24-094622
2024-08-05
Form 10-Q
ID: 0001213900-24-065239